Alpha Crest Capital Management LLC Ultragenyx Pharmaceutical Inc. Transaction History

Alpha Crest Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $974,344 - $1.61 Million	24,383 New	24,383 $1.01 Million
Q2 2022 Aug 11, 2022	SELL	$45.8 - $85.4 $321,287 - $599,081	-7,015 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$62.2 - $84.4 $231,695 - $314,390	3,725 Added 113.22%	7,015 $509,000
Q4 2021 Feb 09, 2022	SELL	$73.71 - $87.86 $232,776 - $277,461	-3,158 Reduced 48.98%	3,290 $277,000
Q3 2021 Nov 10, 2021	SELL	$77.92 - $102.4 $495,025 - $650,547	-6,353 Reduced 49.63%	6,448 $582,000
Q2 2021 Aug 12, 2021	BUY	$92.19 - $115.71 $1.18 Million - $1.48 Million	12,801 New	12,801 $1.22 Million
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $552,144 - $1.16 Million	-6,542 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$72.98 - $90.0 $277,324 - $342,000	3,800 Added 138.58%	6,542 $538,000
Q2 2020 Aug 12, 2020	SELL	$46.91 - $78.22 $214,566 - $357,778	-4,574 Reduced 62.52%	2,742 $214,000
Q1 2020 May 13, 2020	BUY	$33.8 - $62.9 $247,280 - $460,176	7,316 New	7,316 $325,000
Q3 2019 Nov 12, 2019	SELL	$42.5 - $63.11 $183,217 - $272,067	-4,311 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$54.93 - $74.36 $236,803 - $320,565	4,311 New	4,311 $274,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.